Loading…
Attending this event?
Back To Schedule
Tuesday, June 21 • 4:15pm - 5:15pm
#269: Strategic Planning in Selecting the Right Countries and Sites for Clinical Trials

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session
Level: Advanced
CE: ACPE 1.00 Knowledge UAN: 0286-0000-22-582-L04-P ; CME 1.00; RN 1.00

Global clinical trials are a core pillar of many pharmaceutical product development strategies. But, selecting the right countries considering the various attributes of success and regulatory needs is essential. This session will discuss processes for making country inclusion recommendations along with the different factors to consider when deciding on country inclusion or exclusion.

Learning Objectives

Describe the critical attributes commonly included in strategic country selection for global trials; Discuss other elements (regulatory, marketing, diversity and inclusion) should be considered; Identify common data sources used to make country inclusion decisions; Discuss future areas for exploration, including use of real-world data.

Chair

Earl Seltzer, MBA

Speaker

Strategic Global Feasibility Considerations: Past, Present, Future
Stathis Stathelos, MPharm, MSc, PMP

Moving Data-Enabled Strategy to Execution: Innovative Pathways to Success
Nicole Turner, MBA

Integration of Real-World Claims Data to Inform Strategic Decisions for Trial Planning
Jeff Fairbairn, MBA

Aggregating Disparate Data Sources to Develop a Well Rounded Trial Strategy
Jason Gagner, MBA, MS



Speakers
avatar for Jeff Fairbairn

Jeff Fairbairn

Vice President, Account Strategy, Komodo Health, United States
Mr. Fairbairn is an AVP, Account Strategy at Komodo Health, where he helps sponsors and CROs optimize site selection and accelerate patient recruitment using Komodo's unrivaled data. Prior to Komodo, Jeff had operational roles at Decision Resources Group (2 years) and Parexel (10... Read More →
JG

Jason Gagner

Director, Data Services, Parexel, United States
As a Director in the Scientific Data Organization (SDO) at Parexel, Jason is responsible for the oversight and management of scientific data solution development, scientific data project start-up within the Americas, and global real world data strategies. Jason is the lead contact... Read More →
avatar for Earl Seltzer

Earl Seltzer

Senior Director, Global Feasibility, Labcorp Drug Development, United States
Earl Seltzer has over 17 years of industry experience shared across clinical investigator sites in the United States and working at CROs in the strategic planning and feasibility space. At Labcorp, Mr Seltzer leads the global feasibility team as part of the larger, feasibility recruitment... Read More →
avatar for Stathis Stathelos

Stathis Stathelos

Director, Strategic Feasibility and Analytics - Oncology Team Lead, AstraZeneca, United Kingdom
A highly motivated professional in Global Pharmaceutical Development with clinical Pharmacist background. I have more than 16 years of experience in the pharmaceutical industry across several roles in CROs, Biotech and Pharma. Having started my career in clinical trial operations... Read More →
avatar for Nicole Turner

Nicole Turner

Director, Oncology Data Science Portfolio Management, Global Development, Janssen R&D, LLC, United States
Nicole is responsible for leading and executing the Data Science strategy for clinical trial feasibility and analytical process optimization at Janssen. Prior to this role, Nicole served as the Immunology Global Therapeutic Area Head in the Feasibility Center of Excellence. Prior... Read More →


Tuesday June 21, 2022 4:15pm - 5:15pm CDT
Room 183 C McCormick Place 2301 South Indiana Avenue Gate 40 Chicago, IL 60616